Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth
Authors:
- 22 September 2012
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 38 (11) , 1738-1750
Abstract
Gut overgrowth is the pathophysiological event in the critically ill requiring intensive care. In relation to the risk of developing a clinically important outcome, gut overgrowth is defined as ≥105 potential pathogens including ‘abnormal’ aerobic Gram-negative bacilli (AGNB), ‘normal’ bacteria and yeasts, per mL of digestive tract secretion. Surveillance samples of throat and gut are the only samples to detect overgrowth. Gut overgrowth is the crucial event which precedes both primary and secondary endogenous infection, and a risk factor for the development of de novo resistance. Selective decontamination of the digestive tract (SDD) is an antimicrobial prophylaxis designed to control overgrowth. There have been 65 randomised controlled trials of SDD in 15,000 patients over 25 years and 11 meta-analyses, which are reviewed. These trials demonstrate that the full SDD regimen using parenteral and enteral antimicrobials reduces lower airway infection by 72 %, blood stream infection by 37 %, and mortality by 29 %. Resistance is also controlled. Parenteral cefotaxime which reaches high salivary and biliary concentrations eradicates overgrowth of ‘normal’ bacteria such as Staphylococcus aureus in the throat. Enteral polyenes control ‘normal’ Candida species. Enteral polymyxin and tobramycin, eradicate, or prevent gut overgrowth of ‘abnormal’ AGNB. Enteral vancomycin controls overgrowth of ‘abnormal’ methicillin-resistant S. aureus. SDD controls overgrowth by achieving high antimicrobial concentrations effective against ‘normal’ and ‘abnormal’ potential pathogens rather than by selectivity.Keywords
This publication has 149 references indexed in Scilit:
- Is Selective Digestive Decontamination Useful in Controlling Aerobic Gram-Negative Bacilli Producing Extended Spectrum Beta-Lactamases?Microbial Drug Resistance, 2011
- Probiotics versus antibiotic decontamination of the digestive tract: infection and mortalityIntensive Care Medicine, 2010
- Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced MutagenesisMolecular Cell, 2010
- Selective Decontamination of the Digestive Tract (SDD). Twenty-five Years of European Experience2009
- A prospective study of septicaemia on a paediatric oncology unit: A three-year experience at The Royal Liverpool Children’s Hospital, Alder Hey, UKEuropean Journal of Cancer, 2005
- Selective decontamination of the digestive tract: 13 years on, what it is and what it is notIntensive Care Medicine, 1996
- Selective decontamination of the digestive tract reduces Gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantationCritical Care Medicine, 1994
- Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tractIntensive Care Medicine, 1992
- Levels of Cefotaxime in Body Fluids and Tissues: A ReviewClinical Infectious Diseases, 1982
- Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various dosesInfection, 1982